Immunisation with nirsevimab reduced bronchiolitis-related hospitalisations among infants younger than 3 months who visited the emergency department (ED), according to a new study. Nirsevimab also ...

Infants aged 2 years or younger with bronchiolitis faced an increased risk for hospitalization due to air pollution, with a meta-analysis indicating a positive association between exposure to elevated ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...

As colder weather sets in, pediatric hospitals are seeing an increase in infants and young children diagnosed with respiratory syncytial virus (RSV) infections. RSV can lead to severe respiratory ...

Giving the long-acting monoclonal antibody nirsevimab to most infants sharply reduced hospitalizations and clinic visits ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the treatment ...

The NHS warns parents about winter illnesses affecting babies, with a new flu variant and bronchiolitis causing hospital ...

NHS doctor Dr Ahmed Ezzat has shared his top five tips on what you can do to help ease your child's RSV and bronchiolitis symptoms from your home.